Tag

Stuart Raetzman

Stuart Raetzman Appointed as Interim CEO at TearClear

UF startup and UF Innovate | Sid Martin Biotech resident client TearClear has appointed Stuart Raetzman as interim CEO and is preparing for a pivotal study on proprietary latanoprost for glaucoma treatment, according to a press release.
X